Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors

被引:0
|
作者
Érica Cristina Moreno Nascimento
João B. L. Martins
机构
[1] Universidade de Brasília,Laboratório de Química Computacional, LQC
[2] Instituto de Química,undefined
来源
关键词
Acetylcholinesterase inhibitors; Alzheimer´s disease; B3LYP; Molecular modeling; PCA;
D O I
暂无
中图分类号
学科分类号
摘要
Hartree-Fock and density functional methods were used to analyze electronic and structural properties of known drugs to evaluate the influence of these data on acetylcholinesterase inhibition. The energies of the frontier orbitals and the distances between the more acidic hydrogen species were investigated to determine their contributions to the activity of a group of acetylcholinesterase inhibitors. Electrostatic potential maps indicated suitable sites for drugs-enzyme interactions. In this study, the structural, electronic and spatial properties of nine drugs with known inhibitory effects on acetylcholinesterase were examined. The data were obtained based on calculations at the B3LYP/6-31 + G(d,p) level. Multivariate principal components analysis was applied to 18 parameters to determine the pharmacophoric profile of acetylcholinesterase inhibitors. Desirable features for acetylcholinesterase inhibitor molecules include aromatic systems or groups that simulate the surface electrostatic potential of aromatic systems and the presence of a sufficient number of hydrogen acceptors and few hydrogen donors. PCA showed that electronic properties, including the HOMO-1 orbital energy, logP and aromatic system quantity, as well as structural data, such as volume, size and H-H distance, are the most significant properties.
引用
收藏
页码:1371 / 1379
页数:8
相关论文
共 50 条
  • [21] Non-covalent inhibitors of the 20S proteasome
    García-Echeverría, C
    Imbach, P
    Roesel, J
    Fuerst, P
    Lang, M
    Guagnano, V
    Noorani, M
    Zimmermann, J
    Furet, P
    CHIMIA, 2003, 57 (04) : 179 - 181
  • [22] Non-covalent cathepsin K inhibitors for the treatment of osteoporosis
    Kim, TS
    Tasker, AS
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (04) : 355 - 360
  • [23] Non-Covalent Catalysts
    Novikov, Alexander S.
    CATALYSTS, 2023, 13 (02)
  • [24] Non-covalent dendrimers
    Gross, M
    CHEMISTRY WORLD, 2005, 2 (04): : 14 - 14
  • [25] Challenges for the Discovery of Non-Covalent WRN Helicase Inhibitors
    Heuser, Alisa
    Rahman, Wassim Abdul
    Bechter, Elisabeth
    Blank, Jutta
    Buhr, Sylvia
    Erdmann, Dirk
    Fontana, Patrizia
    Mermet-Meillon, Fanny
    Meyerhofer, Marco
    Strang, Ross
    Schrapp, Maxime
    Zimmermann, Catherine
    Cortes-Cros, Marta
    Mobitz, Henrik
    Hamon, Jacques
    CHEMMEDCHEM, 2024, 19 (08)
  • [26] Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
    Zhang, Shizhong
    Malik, Sumeet
    Ali, Nisar
    Khan, Adnan
    Bilal, Mohammad
    Rasool, Kashif
    TOPICS IN CURRENT CHEMISTRY, 2022, 380 (05)
  • [27] THEORETICAL CONFORMATIONAL-ANALYSIS OF NON-COVALENT COMPLEXES OF CARBOXYPEPTIDASE A WITH INHIBITORS AND SUBSTRATES
    LIPKIND, GM
    PASLEN, VV
    MOLECULAR BIOLOGY, 1980, 14 (05) : 904 - 911
  • [28] Covalent and non-covalent binding of metal complexes to RNA
    Alberti, Elena
    Zampakou, Marianthi
    Donghi, Daniela
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2016, 163 : 278 - 291
  • [29] Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
    Shizhong Zhang
    Sumeet Malik
    Nisar Ali
    Adnan Khan
    Muhammad Bilal
    Kashif Rasool
    Topics in Current Chemistry, 2022, 380
  • [30] Non-covalent interactions – QTAIM and NBO analysis
    Sławomir J. Grabowski
    Journal of Molecular Modeling, 2013, 19 : 4713 - 4721